Edap Tms (NASDAQ:EDAP) Upgraded by StockNews.com to “Hold”

Edap Tms (NASDAQ:EDAP) was upgraded by equities researchers at StockNews.com from a “sell” rating to a “hold” rating in a report issued on Monday.

Separately, HC Wainwright reissued a “buy” rating and issued a $19.00 target price on shares of Edap Tms in a report on Monday, July 22nd.

Edap Tms Price Performance

EDAP stock traded down $0.93 during trading on Monday, hitting $3.12. 522,098 shares of the stock traded hands, compared to its average volume of 38,467. The stock has a market cap of $115.76 million, a price-to-earnings ratio of -5.78 and a beta of 0.45. Edap Tms has a one year low of $3.10 and a one year high of $8.50. The company has a current ratio of 2.62, a quick ratio of 2.00 and a debt-to-equity ratio of 0.08. The company has a 50 day simple moving average of $4.81 and a 200 day simple moving average of $6.08.

Hedge Funds Weigh In On Edap Tms

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Virtu Financial LLC acquired a new stake in Edap Tms during the 1st quarter worth approximately $82,000. Miracle Mile Advisors LLC bought a new stake in Edap Tms in the 1st quarter valued at $136,000. Roubaix Capital LLC bought a new position in Edap Tms during the 1st quarter worth about $169,000. Finally, Commonwealth Equity Services LLC raised its stake in shares of Edap Tms by 5.9% in the 2nd quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock valued at $388,000 after purchasing an additional 4,000 shares during the period. Institutional investors own 62.74% of the company’s stock.

About Edap Tms

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.